Early Convalescent Plasma for High-Risk Outpatients with Covid-19.
Frederick K KorleyValerie Durkalski-MauldinSharon D YeattsKevin SchulmanRobertson D DavenportLarry J DumontNahed El KassarLydia D FosterJennifer M HahSiddartha JaiswalAlesia KaplanEzekiel LowellJohn F McDyerJames QuinnDarrell J TriulziCarol Van HuysenValerie L W StevensonKabir YadavChristopher W JonesBory KeaAaron BurnettJoshua C ReynoldsColin F GreinederNathan L HaasDavid G BeiserRobert SilbergleitWilliam BarsanClifton W Callawaynull nullPublished in: The New England journal of medicine (2021)
The administration of Covid-19 convalescent plasma to high-risk outpatients within 1 week after the onset of symptoms of Covid-19 did not prevent disease progression. (SIREN-C3PO ClinicalTrials.gov number, NCT04355767.).